What Causes Low Platelet Count?

Thrombocytopenia—the medical term for a low platelet count—is a common hematologic finding that can arise from a wide spectrum of underlying causes. Platelets, or thrombocytes, are small anucleate cell fragments essential for hemostasis; a normal count ranges from 150,000 to 400,000 per microliter of blood. Clinically significant thrombocytopenia is typically defined as a platelet count below 150,000/µL, with increased bleeding risk becoming more pronounced below 50,000/µL and spontaneous hemorrhage possible below 10,000/µL.

The etiology of thrombocytopenia falls broadly into three mechanistic categories: decreased production, increased destruction or consumption, and sequestration. Decreased bone marrow production may result from conditions such as aplastic anemia, myelodysplastic syndromes, leukemia, lymphoma, or metastatic solid tumors infiltrating the marrow. Chemotherapy, radiation therapy, and certain medications—including thiazide diuretics, valproic acid, and linezolid—can also suppress megakaryopoiesis. Nutritional deficiencies, particularly of vitamin B₁₂ or folate, impair DNA synthesis in megakaryocyte precursors and contribute to reduced platelet output.

Increased peripheral platelet destruction or consumption includes immune-mediated processes like immune thrombocytopenia (ITP), drug-induced immune thrombocytopenia (e.g., heparin-induced thrombocytopenia or HIT), and autoimmune disorders such as systemic lupus erythematosus. Non-immune mechanisms include disseminated intravascular coagulation (DIC), thrombotic microangiopathies (e.g., thrombotic thrombocytopenic purpura and hemolytic uremic syndrome), and severe infections—particularly sepsis or viral illnesses like HIV, Epstein-Barr virus, or SARS-CoV-2.

Platelet sequestration—most commonly due to splenomegaly—occurs when an enlarged spleen traps and retains excessive numbers of platelets, reducing their circulating availability. This is frequently seen in chronic liver disease with portal hypertension, lymphoproliferative disorders, or certain storage diseases.

Accurate diagnosis requires careful clinical evaluation, including a detailed medication history, physical examination for signs of bleeding or organomegaly, and targeted laboratory testing—such as peripheral blood smear review, reticulated platelet count, direct antiglobulin test, coagulation studies, and, when indicated, bone marrow aspiration and biopsy. Management is directed at the underlying cause and may involve corticosteroids, intravenous immunoglobulin, thrombopoietin receptor agonists, splenectomy, or discontinuation of offending agents.